Form4insider filings, from the source

SEC Form 4 · accession 0001437749-18-007129

CESCA THERAPEUTICS INC. · KOOL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Xiaochun Xu
Officer — President and CEO · Director · 10% Owner
Period of report
Apr 16, 2018
Accepted (ET)
Apr 18, 2018 · 7:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811212

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Second Amended and Restated Convertible Promissory NoteF1,F2$1.61Apr 16, 2018A—AApr 16, 2018Mar 6, 2022Common Stock, par value $.001 per share6,211,18010,000,000I

Explanation of responses